Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM)
CUSIP: 690145206
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value of $0.001 per share
- Shares outstanding
- 18,116,200
- Total 13F shares
- 18,242,288
- Share change
- +3,563,655
- Total reported value
- $350,434,222
- Put/Call ratio
- 0%
- Price per share
- $19.21
- Number of holders
- 91
- Value change
- +$69,197,262
- Number of buys
- 62
- Number of sells
- 22
Quarterly Holders Quick Answers
What is CUSIP 690145206?
CUSIP 690145206 identifies OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 690145206:
Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value of $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Durable Capital Partners LP |
13D/G
13F
|
Company |
9.9%
|
26,609,101
|
$154,630,808 | $0 | 03 Jan 2025 | |
| FMR LLC |
13D/G
13F
|
Company |
14%
|
2,596,861
|
$30,149,556 | $0 | 31 Mar 2025 | |
| VANGUARD GROUP INC |
13D/G
13F
|
The Vanguard Group · Company |
5.6%
|
991,429
|
$18,919,737 | $0 | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
13D/G
|
Company |
9.6%
from 13D/G
|
1,703,083
|
$18,836,098 | — | 31 Mar 2025 | |
| PFM Health Sciences, LP |
13F
|
Company |
9.3%
|
1,685,727
|
$18,644,141 | — | 31 Mar 2025 | |
| T. Rowe Price Investment Management, Inc. |
13F
|
Company |
8.8%
|
1,603,056
|
$17,730,000 | — | 31 Mar 2025 | |
| Woodline Partners LP |
13D/G
13F
|
Company |
7.5%
|
1,325,784
|
$15,392,352 | $0 | 31 Mar 2025 | |
| PERCEPTIVE ADVISORS LLC |
13D/G
13F
|
Company |
6.7%
|
1,208,334
|
$14,028,758 | $0 | 31 Mar 2025 | |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ |
13F
|
Company |
4.6%
|
840,248
|
$9,293,143 | — | 31 Mar 2025 | |
| MARSHALL WACE, LLP |
13F
|
Company |
3.6%
|
650,264
|
$7,191,919 | — | 31 Mar 2025 | |
| Hackett Patrick T. |
3/4/5
|
Director |
1.2%
|
220,171
|
$3,368,614 | — | 02 Jun 2025 | |
| Parkman Healthcare Partners LLC |
13F
|
Company |
1.3%
|
231,099
|
$2,555,955 | — | 31 Mar 2025 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1%
|
190,156
|
$2,103,123 | — | 31 Mar 2025 | |
| Renee Gaeta |
3/4/5
|
Chief Financial Officer |
0.73%
|
131,425
|
$2,010,802 | — | 10 Jun 2025 | |
| Catalio Capital Management, LP |
13F
|
Company |
0.92%
|
166,666
|
$1,843,326 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.64%
|
115,061
|
$1,272,575 | — | 31 Mar 2025 | |
| Steven S. Williamson |
3/4/5
|
Chief Commercial Officer |
—
class O/S missing
|
320,347
|
$1,143,639 | — | 15 Feb 2024 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.54%
|
98,108
|
$1,085,074 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.49%
|
89,299
|
$985,000 | — | 31 Mar 2025 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.47%
|
84,457
|
$934,094 | — | 31 Mar 2025 | |
| Jean-Olivier Racine |
3/4/5
|
Chief Technology Officer |
—
class O/S missing
|
265,325
|
$867,613 | — | 10 May 2024 | |
| PURA VIDA INVESTMENTS, LLC |
13F
|
Company |
0.03%
|
5,000
|
$783,417 | — | 31 Mar 2025 | |
| C WorldWide Group Holding A/S |
13F
|
Company |
0.37%
|
66,666
|
$737,000 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.36%
|
65,918
|
$729,048 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.36%
|
64,694
|
$715,525 | — | 31 Mar 2025 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.29%
|
53,267
|
$589,129 | — | 31 Mar 2025 | |
| Brent D. Lang |
3/4/5
|
Director |
0.19%
|
34,517
|
$528,109 | — | 02 Jun 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.23%
|
41,206
|
$455,738 | — | 31 Mar 2025 | |
| Martin Vazquez |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
146,619
mixed-class rows
|
$442,350 | — | 01 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.22%
|
39,356
|
$435,534 | — | 31 Mar 2025 | |
| D. Keith Grossman |
3/4/5
|
Director |
0.15%
|
26,763
|
$409,473 | — | 02 Jun 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.19%
|
33,912
|
$375,067 | — | 31 Mar 2025 | |
| Kevin C. Oboyle |
3/4/5
|
Director |
0.13%
|
24,118
|
$369,005 | — | 02 Jun 2025 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.15%
|
27,381
|
$303,000 | — | 31 Mar 2025 | |
| Nabeel Ahmed |
3/4/5
|
Chief Financial Officer |
0.09%
|
16,096
|
$286,669 | -$10,401 | 15 May 2025 | |
| James F. Hinrichs. |
3/4/5
|
Director |
—
class O/S missing
|
80,349
|
$283,632 | — | 29 May 2024 | |
| Birchview Capital, LP |
13F
|
Company |
0.13%
|
24,584
|
$271,899 | — | 31 Mar 2025 | |
| Stacey L. Porter |
3/4/5
|
Chief People Officer |
—
class O/S missing
|
61,448
|
$263,612 | — | 12 Jan 2024 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.13%
|
22,978
|
$254,135 | — | 31 Mar 2025 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.12%
|
20,992
|
$232,172 | — | 31 Mar 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.1%
|
17,602
|
$194,502 | — | 31 Mar 2025 | |
| Andrea Lynn Saia |
3/4/5
|
Director |
0.07%
|
12,175
|
$186,277 | — | 02 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.09%
|
16,288
|
$180,145 | — | 31 Mar 2025 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
15,461
|
$170,999 | — | 31 Mar 2025 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.08%
|
14,818
|
$163,000 | — | 31 Mar 2025 | |
| Dale E. Jones |
3/4/5
|
Director |
—
class O/S missing
|
45,918
|
$162,091 | — | 29 May 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
12,101
|
$133,837 | — | 31 Mar 2025 | |
| TUDOR INVESTMENT CORP ET AL |
13F
|
Company |
0.07%
|
12,028
|
$133,030 | — | 31 Mar 2025 | |
| Catherine M. Szyman |
3/4/5
|
Director |
—
class O/S missing
|
24,596
|
$105,517 | — | 31 May 2023 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.03%
|
5,419
|
$59,934 | — | 31 Mar 2025 |
Institutional Holders of Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) as of Q2 2025
As of 30 Jun 2025,
Outset Medical, Inc. - Common Stock, par value of $0.001 per share (OM) was held by
91 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,242,288 shares.
The largest 10 holders included
FMR LLC, PFM Health Sciences, LP, Durable Capital Partners LP, T. Rowe Price Investment Management, Inc., Alyeska Investment Group, L.P., Woodline Partners LP, VANGUARD GROUP INC, BlackRock, Inc., PERCEPTIVE ADVISORS LLC, and MASSACHUSETTS FINANCIAL SERVICES CO /MA/.
This page lists
91
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
59
Q2 2025 holders
91
Holder diff
32
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.